Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 09-2011 | 09-2010 | 09-2009 | 09-2008 | |
| Operating Expenses | 19,299 | 23,222 | 37,157 | 43,319 | 47,354 |
| Operating Income | -19,299 | -23,222 | -37,157 | -43,319 | -47,354 |
| Other Income | -1,430 | 12,671 | -1,237 | 386 | 3,010 |
| Pre-tax Income | -20,729 | -10,551 | -38,394 | -42,933 | -44,344 |
| Income Tax | 18 | 41 | -104 | 337 | -983 |
| Net Income Continuous | -20,747 | -10,592 | -38,290 | -43,270 | -43,361 |
| Net Income | $-20,747 | $-10,592 | $-38,290 | $-43,270 | $-43,361 |
| EPS Basic Total Ops | -57.36 | -40.84 | -190.39 | -218.62 | -233.03 |
| EPS Basic Continuous Ops | -57.25 | -40.84 | -190.37 | -218.87 | -232.63 |
| EPS Diluted Total Ops | -57.36 | -40.84 | -190.39 | -218.62 | -233.03 |
| EPS Diluted Continuous Ops | -57.25 | -40.84 | -190.37 | -218.87 | -232.63 |
| EBITDA(a) | $-18,574 | $-22,284 | $-36,166 | $-42,442 | $-46,787 |